July 16th 2024
The U.S. Food and Drug Administration and Federal Trade Commission have jointly issued warning letters to five companies for selling copycat food products containing delta-8 THC in violation of the Federal Food Drug and Cosmetic Act.
FDA concludes that CBD needs its own regulatory pathway separate from dietary supplements and food
January 26th 2023The U.S. Food and Drug Administration has reached the conclusion that “a new regulatory pathway for CBD is needed that balances individuals’ desire for access to CBD products with the regulatory oversight needed to manage risks.”